Seventy-three patients undergoing orthognathic surgery were randomly allocated into one of three groups : an angiotensin converting enzyme inhibitor group ( Group A , n = 24 ) with enalapril 10 mg , a blocker group ( Group B , n = 24 ) with atenolol 25 mg , or a control group ( Group C , n = 25 ) with placebo .